Aster Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-256
Closed -$3.17K 1175
2026
Q1
$3.17K Buy
+256
New +$2.35K ﹤0.01% 723
2025
Q2
Sell
-227
Closed -$3.59K 1461
2025
Q1
$3.59K Sell
227
-61
-21% -$863 ﹤0.01% 1141
2024
Q4
$3.99K Sell
288
-67
-19% -$1.06K ﹤0.01% 891
2024
Q3
$5.94K Buy
+355
New +$7.63K ﹤0.01% 878

Other funds holding PRTA

Aster Capital Management's PRTA Position: Q2 2026 in Review

Aster Capital Management sold out of Prothena Corp (PRTA) in Q2 2026, closing a stake of 256 shares — an estimated $3.17K sold.

Aster Capital Management first reported a position in PRTA in Q3 2024 and held it in 4 quarters. The position peaked at $5.94K in Q3 2024. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Aster Capital Management reported no remaining Prothena Corp position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 256 Prothena Corp shares in Q2 2026, an estimated $3.17K.
  • Aster Capital Management first reported a position in Prothena Corp in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Prothena Corp position peaked at $5.94K in Q3 2024.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.